Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
University of Colorado Cancer Center · O'Neal Comprehensive Cancer Center · +41 more institutions
Abstract
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
Citation impact
- FWCI
- 47.39
- Percentile
- 100%
- References
- 272
Authors
35- BNBurt NaborsCorresponding
University of Colorado Cancer Center, O'Neal Comprehensive Cancer Center, University of Colorado Denver
- JPJana Portnow
City Of Hope National Medical Center
- MSManmeet S. Ahluwalia
Cleveland Clinic, Cancer Institute (WIA), University Hospitals Seidman Cancer Center
- JMJoachim M. Baehring
Smilow Cancer Hospital
- HBHenry Brem
Sidney Kimmel Comprehensive Cancer Center
Topics & keywords
- Medicine
- Central nervous system
- Radiation therapy
- Clinical Practice
- Oncology
- Radiation oncology
- Disease
- Internal medicine
- Good health and well-being
Funding
- CRCancer Research Institute
- AAmgen
- BSBristol-Myers Squibb
- AAstraZeneca
- GSGilead Sciences
- TPTakeda Pharmaceuticals North America
- UOUniversity of Pennsylvania
- KTKaryopharm Therapeutics
- VMVarian Medical Systems
- JHJohns Hopkins University
- NPNovartis Pharmaceuticals Corporation
- NCNational Cancer Research Institute
- RPRegeneron Pharmaceuticals
- JPJazz Pharmaceuticals
- NNovocure
- NCNational Comprehensive Cancer Network
- APArbor Pharmaceuticals
- IPINOVIO Pharmaceuticals
- APAgios Pharmaceuticals
- BBeiGene
- BPBoston Pharmaceuticals
- SLSK Life Science
- BHBayer HealthCare
- IIpsen
- NINational Institutes of Health
- GGenentech
- ACAbbVie Canada
- NCNational Cancer Institute